Shopping Cart
Remove All
Your shopping cart is currently empty
Prezalumab (AMG 557) is a human IgG2 monoclonal antibody targeting ICOSL and BAFF, used for studying Sjogren's syndrome, cutaneous lupus erythematosus, psoriasis, systemic lupus erythematosus arthritis, and systemic lupus erythematosus (SLE).
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $247 | - | In Stock | |
| 5 mg | $647 | - | In Stock | |
| 10 mg | $987 | - | In Stock | |
| 25 mg | $1,530 | - | In Stock | |
| 50 mg | $1,980 | - | In Stock | |
| 100 mg | $2,780 | - | In Stock |
| Description | Prezalumab (AMG 557) is a human IgG2 monoclonal antibody targeting ICOSL and BAFF, used for studying Sjogren's syndrome, cutaneous lupus erythematosus, psoriasis, systemic lupus erythematosus arthritis, and systemic lupus erythematosus (SLE). |
| In vivo | In mouse NZB/NZW lupus model and collagen-induced arthritis (CIA) models, Prezalumab demonstrates more efficacious effects than a single ICOSL or BAFF inhibitor[1]. Prezalumab, similar to the pharmacological effect of BAFF inhibition, reduces B cells in cynomolgus monkeys[1]. |
| Synonyms | AMG 557 |
| Molecular Weight | 145.42 kDa |
| Cas No. | 1523164-68-2 |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.